These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 1729321
1. Dissociation of termination and prevention of inducibility of sustained ventricular tachycardia with infusion of procainamide: evidence for distinct mechanisms. Callans DJ, Marchlinski FE. J Am Coll Cardiol; 1992 Jan; 19(1):111-7. PubMed ID: 1729321 [Abstract] [Full Text] [Related]
2. Effects of incremental doses of procainamide on ventricular refractoriness, intraventricular conduction, and induction of ventricular tachycardia. Morady F, DiCarlo LA, de Buitleir M, Krol RB, Baerman JM, Kou WH. Circulation; 1986 Dec; 74(6):1355-64. PubMed ID: 2430731 [Abstract] [Full Text] [Related]
9. Amiodarone versus amiodarone and a type IA agent for treatment of patients with rapid ventricular tachycardia. Marchlinski FE, Buxton AE, Miller JM, Vassallo JA, Flores BT, Josephson ME. Circulation; 1986 Nov; 74(5):1037-43. PubMed ID: 3769163 [Abstract] [Full Text] [Related]
10. Coronary venous retroinfusion of procainamide: a new approach for the management of spontaneous and inducible sustained ventricular tachycardia during myocardial infarction. Karagueuzian HS, Ohta M, Drury JK, Fishbein MC, Meerbaum S, Corday E, Mandel WJ, Peter T. J Am Coll Cardiol; 1986 Mar; 7(3):551-63. PubMed ID: 3950235 [Abstract] [Full Text] [Related]
14. Termination of ventricular tachycardia: role of tachycardia cycle length. Roy D, Waxman HL, Buxton AE, Marchlinski FE, Cain ME, Gardner MJ, Josephson ME. Am J Cardiol; 1982 Dec; 50(6):1346-50. PubMed ID: 7148712 [Abstract] [Full Text] [Related]
15. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease. Buxton AE, Rosenthal ME, Marchlinski FE, Miller JM, Flores B, Josephson ME. Am J Cardiol; 1991 Apr 15; 67(9):835-42. PubMed ID: 1707220 [Abstract] [Full Text] [Related]
16. The role of combination therapy with mexiletine and procainamide in patients with inducible sustained ventricular tachycardia refractory to intravenous procainamide. Widerhorn J, Sager PT, Rahimtoola SH, Bhandari AK. Pacing Clin Electrophysiol; 1991 Mar 15; 14(3):420-6. PubMed ID: 1708872 [Abstract] [Full Text] [Related]
17. Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. Ortiz M, Martín A, Arribas F, Coll-Vinent B, Del Arco C, Peinado R, Almendral J, PROCAMIO Study Investigators. Eur Heart J; 2017 May 01; 38(17):1329-1335. PubMed ID: 27354046 [Abstract] [Full Text] [Related]
19. The efficacy, electrophysiologic and electrocardiographic effects of intravenous pirmenol, a new class I antiarrhythmic agent, in patients with ventricular tachycardia: comparison with procainamide. Gold RL, Frumin H, Haffajee CI, Kerin NZ, Jarandilla R. Pacing Clin Electrophysiol; 1988 Mar 01; 11(3):308-14. PubMed ID: 2452418 [Abstract] [Full Text] [Related]
20. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy. Markel ML, Miles WM, Luck JC, Klein LS, Prystowsky EN. Circulation; 1993 Mar 01; 87(3):783-92. PubMed ID: 8443899 [Abstract] [Full Text] [Related] Page: [Next] [New Search]